Jump Financial’s Aquestive Therapeutics AQST Stock Holding History

Jump Financial’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-246,840	Closed	-$1.59M	–	1867
2025 Q4	$1.59M	Buy	246,840 +226,242	+1,098%	+$1.41M	0.02%	774
2025 Q3	$115K	Buy	+20,598	New	+$89.1K	﹤0.01%	1680
2024 Q3	–	Sell	-130,920	Closed	-$340K	–	1624
2024 Q2	$340K	Buy	130,920 +99,864	+322%	+$334K	0.01%	1326
2024 Q1	$132K	Buy	31,056 +1,244	+4%	+$4.14K	﹤0.01%	1756
2023 Q4	$60.2K	Buy	+29,812	New	+$52.7K	﹤0.01%	1701
2021 Q4	–	Sell	-49,700	Closed	-$216K	–	1361
2021 Q3	$216K	Buy	49,700 +19,070	+62%	+$74.8K	0.02%	830
2021 Q2	$122K	Buy	+30,630	New	+$122K	0.01%	958

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jump Financial's AQST Position: Q1 2026 in Review

Jump Financial sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 246,840 shares — an estimated $1.59M sold.

Jump Financial first reported a position in AQST in Q2 2021 and held it in 7 quarters. The position peaked at $1.59M in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

Jump Financial reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
Jump Financial sold 246,840 Aquestive Therapeutics shares in Q1 2026, an estimated $1.59M.
Jump Financial first reported a position in Aquestive Therapeutics in Q2 2021 and held it in 7 quarters.
Jump Financial's Aquestive Therapeutics position peaked at $1.59M in Q4 2025.
179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.